|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2016
12 months to Dec 31, 2016
|
|
|---|---|---|---|---|---|
| Other | |||||
| REVENUE | |||||
| Health Care | |||||
| Total rEVENUE | |||||
| COST OF SALES | |||||
| Health Care | |||||
| Total cOST OF SALES | |||||
| GROSS PROFIT | |||||
| OPERATING EXPENSES | |||||
| Goodwill impairment | |||||
| Depreciation expense | |||||
| Loss on disposal of fixed assets | |||||
| Share based compensation | |||||
| Selling, general and administrative | |||||
| Total operating expenses | |||||
| INCOME (LOSS) FROM CONTINUING OPERATIONS | |||||
| Other expense | |||||
| OTHER (EXPENSE) INCOME | |||||
| Other expense | |||||
| Gain on debt refinance and forgiveness | |||||
| Penalties and fees | |||||
| Interest expense | |||||
| Amortization of notes payable discount | |||||
| Gain on disposal of fixed assets | |||||
| Total other expenses | |||||
| NET LOSS BEFORE DISCONTINUED OPERATIONS | |||||
| INCOME (LOSS) FROM DISCONTINUED OPERATIONS | |||||
| LOSS FROM DISPOSAL OF DISCONTINUED OPERATIONS | |||||
| NET LOSS FOR THE YEAR | |||||
| PREFERRED STOCK DIVIDENDS | |||||
| NET LOSS ATTRIBUTABLE TO COMMON STOCKHOLDERS | |||||
| CONTINUING OPERATIONS | |||||
| DISCONTINUED OPERATIONS | |||||
| WEIGHTED AVERAGE SHARES OUTSTANDING – BASIC | |||||
| WEIGHTED AVERAGE SHARES OUTSTANDING – DILUTED | |||||
Loading...